WallStreetZenWallStreetZen

NASDAQ: MPLT
Maplight Therapeutics Inc Stock Ownership - Who owns Maplight Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Maplight Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Catalyst4 Inc10% Owner2026-08-144,400,000$11.38
$50.07MBuy
James Woodruff LillieCSci2026-08-0322,082$12.54
$276.91kSell
Catalyst4 Inc10% Owner2026-07-301,000,000$13.00
$13.00MBuy
Catalyst4 Inc10% Owner2026-07-293,000$12.63
$37.89kBuy
Catalyst4 Inc10% Owner2026-07-2865,137$11.69
$761.39kBuy
Catalyst4 Inc10% Owner2026-07-28141,088$10.74
$1.52MBuy
Troy CoxDirector2026-07-2815,620$9.52
$148.70kBuy
Jonathan GillisCFO;CAO;Interim2026-07-17900$38.17
$34.35kSell
Anatol KreitzerCXO2026-07-172,833$37.05
$104.96kSell
Anatol KreitzerCXO2026-07-1714,140$37.70
$533.08kSell

1 of 16

MPLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MPLT insiders and whales buy or sell their stock.

MPLT Shareholders

What type of owners hold Maplight Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Catalyst4 Inc97.04%45,004,153$585.05MInsider
Holdings A. Novo7.95%3,686,622$47.93MInsider
Christopher A. Kroeger3.17%1,471,980$19.14MInsider
Vishwas Setia0.77%356,256$4.63MInsider
Robert C. Malenka0.75%348,138$4.53MInsider
Erin Pennock Foff0.67%312,261$4.06MInsider
James Woodruff Lillie0.45%210,110$2.73MInsider
Anatol Kreitzer0.39%180,926$2.35MInsider
Kristopher Hanson0.33%153,553$2.00MInsider
Jonathan Gillis0.33%152,482$1.98MInsider

1 of 3

MPLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MPLT0.05%99.95%Net BuyingNet Buying
ASMB0.09%63.58%Net BuyingNet Selling
CRMD0.06%9.76%Net SellingNet Selling
OABI0.04%22.94%Net Selling
SLN0.02%0.09%
View Top Biotech Stocks

Maplight Therapeutics Stock Ownership FAQ

Who owns Maplight Therapeutics?

Maplight Therapeutics (NASDAQ: MPLT) is owned by 0.06% institutional shareholders, 112.28% Maplight Therapeutics insiders, and 0.00% retail investors. Catalyst4 Inc is the largest individual Maplight Therapeutics shareholder, owning 45.00M shares representing 97.04% of the company. Catalyst4 Inc's Maplight Therapeutics shares are currently valued at $585.05M.

If you're new to stock investing, here's how to buy Maplight Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.